13
total announcements
VIMTALABS.BO · 15 min delayed
Key Stats · Yahoo Finance · as of 21 Oct 2026
Market Cap
₹2,256 Cr
P/E (TTM)
28.6
P/E (Forward)
66.8
EPS (TTM)
₹17.66
52W Low
₹377.30
52W High
₹736.95
Dividend Yield
0.40%
Beta
-0.10
Price / Book
4.9
Debt / Equity
0.7
Revenue (TTM)
₹421 Cr
Gross Margin
75.17%
Operating Margin
22.70%
Vimta Labs Ltd-$
Vimta Labs Ltd has submitted a certificate pursuant to Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018, confirming compliance for the quarter and half year ended 30th September 2026.
Vimta Labs Ltd-$
Vimta Labs Ltd has announced the closure of its trading window for all designated persons, their immediate relatives, and connected persons from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ended September 30, 2026.
Vimta Labs Ltd-$
Vimta Labs Ltd has allotted 12,955 equity shares under the Vimta Labs Employee Stock Option Plan 2021 to eligible employees, increasing the paid-up share capital from 8,93,73,808 to 8,93,99,718.
Vimta Labs Ltd-$
Vimta Labs Ltd has announced that CARE Ratings Limited has reaffirmed its credit ratings for the company's bank facilities, with a long-term rating of CARE A and a short-term rating of CARE A1.
Vimta Labs Ltd-$
Vimta Labs Ltd has responded to a clarification request from BSE Surveillance regarding an increase in volume of its securities across exchanges, stating that it has made necessary disclosures and the share price movement is due to market factors.
Vimta Labs Ltd-$
The BSE has sought clarification from Vimta Labs Ltd regarding a movement in volume on September 01, 2026.
Vimta Labs Ltd-$
Vimta Labs Ltd has announced the schedule of analyst/institutional investor meet under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meetings will be held on September 4 and 9, 2026, with lead investments and fund managers from Oppenheimer and Abakkus Asset Management, respectively.
Vimta Labs Ltd-$
Vimta Labs Ltd. has announced the schedule of analyst/institutional investors meet, to be held on September 4 and 9, 2026, to discuss the company's business operations. The meetings will be held in a physical and virtual format, respectively. No unpublished price-sensitive information will be shared during the meetings.
Vimta Labs Ltd-$
Vimta Labs Ltd has detected a cyber security incident affecting a part of its IT infrastructure, but operations and customer delivery services have remained fully functional. The company has engaged external cybersecurity experts to assess the matter and support remediation.
Vimta Labs Ltd-$
Vimta Labs Ltd announced an analyst/institutional investors meet on July 3, 2026, to discuss the company's business operations. The meet will be attended by senior portfolio managers and CIOs. No unpublished price-sensitive information will be shared.
Vimta Labs Ltd-$
Vimta Labs Ltd has announced the schedule of analyst/institutional investors meet to discuss the company's business operations.
Vimta Labs Ltd-$
Vimta Labs Ltd reported Q1 FY 2027 results with total income of INR1,129 million, a 13.7% year-on-year growth, driven by strong performance in pharma contract research and testing services and clinical research operations. The company navigated near-term headwinds and sustained healthy profitability.
Vimta Labs Ltd-$
Vimta Labs Ltd has published unaudited financial results for the quarter ended 30th June 2026, in compliance with Regulation 33 and 47 of the SEBI (LODR) Regulations, 2015. The results are available on the company's website and on the websites of BSE Limited and National Stock Exchange of India Limited.